CONGRESS PRESIDENTS: Olivier Glehen (Lyon, France), Martin Hübner (Lausanne, Switzerland), Hyung-Ho Kim (Seoul, South Korea),
Michael Bau Mortensen (Odense, Denmark), Marc Pocard (Paris, France), Marc Reymond (Tübingen, Germany), Jimmy So (Singapore)
SYMPOSIUM
5TH INTERNATIONAL
UNDERSTANDING PERITONEAL METASTASIS
September 7th & 8th 2018FONDATION DOSNE-THIERS, PARIS, FRANCE
www.pipac.fr FINAL PROGRAM
SYMPOSIUM
5TH INTERNATIONAL
UNDERSTANDING PERITONEAL METASTASIS
FINAL PROGRAM
Friday, September 7th
07:15 Welcome desk opening
SESSION 1 – TECHNOLOGY SESSION
08:00 HINAT, S. Reck (Stuttgart, Germany)
08:15 PIPAC, P. Horvath (Tübingen, Germany)
08:30 ePIPAC, I. Sautkin (Omsk, Russia)
08:45 hPIPAC, H. H. Kim (Seoul, South Korea)
SESSION 2 – PHARMACOLOGY SESSION, PHASE-I STUDIES
09:00 Dose escalation study of PIPAC with oxaliplatin, J. So (Singapore)
09:15 PIPOX, F. Dumont (Nantes, France)
09:30 nab-Paclitaxel, W. Willaert (Gent, Belgium)
09:45 ePIPAC, K. Rovers (Eindhoven, The Netherlands)
10:00 Coffee break
SESSION 3 – STATE OF THE ART LECTURES
10:30 PIPAC in ovarian cancer: state of the art, C. B. Tempfer (Herne, Germany)
11:00 PIPAC in gastrointestinal cancer: state of the art, M. Hübner (Lausanne, Switzerland)
11:30 International Society for the study of Pleura and Peritoneum (ISSPP), M. A. Reymond (Tübingen, Germany)
12:00 Lunch
SESSION 4 – CLINICAL STUDIES: PHASE-2
13:00 PIPAC-GA1, F. Struller (Tübingen, Germany)
13:15 PIPAC-GA2, V. Khomiakov (Moskow, Russia)
13:30 PARROT, G. Vizzielli (Rome, Italy)
13:45 PI-CaP, M. Robella (Turin, Italy) 14:00 PIPAC-OPC2 & PIPAC-OPC3,
M. Graversen (Odense, Denmark)
14:15 Pause
SESSION 5 – CLINICAL STUDIES: RANDOMIZED TRIALS
14:45 PMGA-PIPAC, B. Rau (Berlin, Germany)
15:00 uGI-PIPAC, T. Goetze (Frankfurt, Germany)
15:15 PIPAC in platin-resistant ovarian cancer: a randomized trial, S. P. Somashekhar (Bengalore, India)
15:30 Quality of life assessment under PIPAC therapy: a randomized trial, S. P. Somashekhar (Bengalore, India)
15:45 PIPAC-Estok, C. Eveno (Paris, France)
16:00 PIPAC-OV3, N. Bakrin (Lyon, France)
16:15 CRC-PIPAC 2, K. Rovers (Eindhoven, The Netherlands)
16:30 GC-PIPAC 2, K. Rovers (Eindhoven, The Netherlands)
16:45 Summary of the day
17:00 End of the day
19:30 Gala dinner
SYMPOSIUM
5TH INTERNATIONAL
UNDERSTANDING PERITONEAL METASTASIS
FINAL PROGRAM
Saturday, September 8th
WORKING GROUPS
ROOM A
08:00 PIPAC-0V3 trial study meeting*, N. Bakrin (Lyon, France)
ROOM B
08:00 PRGS pathology meeting*, W. Solass (Tübingen, Germany)
ROOM C
08:00 Workshop Scanning Electron Microscope*, C. Pape (Darmstadt, Germany)
ROOM E
08:00 PIPAC international registry*, M. B. Mortensen (Odense, Denmark)
CONFEENCE ROOM
08:00 Free papers presentation, W. Ceelen (Ghent, Belgium) & R. Wilson (Sidney, Australia)
10:00 Coffee break
CHARLES SURH LECTURE
10:30 Laudatio, M. A. Reymond (Tübingen, Germany)
From Huang Di to Henry Head - 2000 years of segmental phenomena, F. Beissner (Hanover, Germany)
INTERNATIONAL SOCIETY FOR THE STUDY OF PLEURA AND PERITONEUM
M. Pocard (Paris, France)
11:00 Creation of the society Approval of statute Election of the first president Election of the executive committee Press release Official picture in the historical library
12:00 Award for the best communication, W. Ceelen (Ghent, Belgium) & R. Wilson (Sidney, Australia)
Invitation to the 6th PIPAC meeting, Singapore 2019, J. So (Singapore)
12:15 Farewell, M. Pocard (Paris, France)
SCIENTIFIC COMMITTEE
ACKNOWLEDGMENTSMAJOR SPONSOR
GI TUMORSPr Clarisse EvenoDr Philipp HorvathPr Martin HubnerDr Florian StrullerGYNECOLOGYPr Clemens TempferEXPERIMENTALPr Wim CeelenPr Marc PocardPr Robert Wilson
PHARMACOLOGYDr Ranjita SahooTECHNOLOGYPr Marc ReymondCLINICAL, PATHOLOGYDr Wiebke SolassSTATISTICSDr Tarkan Jäger
*On invitation.
SPONSORS